Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 09, 2024

Compliance With the Pregnancy Prevention Program Among Women Initiating Isotretinoin Treatment Between 2014 and 2021

Journal of the European Academy of Dermatology and Venereology: JEADV


Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Compliance with the pregnancy prevention program among women initiating isotretinoin treatment between 2014 and 2021: A nationwide cohort study on the French Health Data System (SNDS)
J Eur Acad Dermatol Venereol 2024 May 19;[EPub Ahead of Print], A Havet, C Bouvard, A Moskal, M Chanelière, J Massardier, B Lebrun-Vignes, AP Jonville-Bera, C Payet, M Viprey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading